The stability of ascorbic acid in serum and plasma prior to analysis was studied.
Introduction
Research into the functions of vitamin C (L-ascorbic acid and dehydroascorbic acid) in vivo has been extensive, and in recent years has centred on its role as a powerful plasma antioxidant capable of moderating the oxidative stress e¡ects of various diseases. 1 Vitamin C can be measured reliably in biological samples by high-performance liquid chromatography (HPLC) with electrochemical detection. 2 However, it is well known that ascorbic acid in blood, serum or plasma at neutral pH is rapidly destroyed by oxidation. This process can be minimized by the use of metal chelators such as EDTA and protein-precipitating agents such as metaphosphoric acid and dithiothreitol (DTT), either singly or in combination, or perchloric acid (HClO 4 ). 3--5 Inevitably, though, delays occur between sample collection and preservation and this can lead to inaccurate results. This problem appears to have been poorly addressed in the literature.
Losses of ascorbic acid from blood specimens can be minimized by removing the cells, deproteinizing and preserving immediately following phlebotomy. However, since specimen collection centres are often remote from the laboratory performing the test, there can be delays before the sample is correctly preserved. Such delays can occur between specimen collection and separation of the sample from the cells or before deproteinization and preservation can be carried out. The aim of this study was to determine the e¡ect of delays in either separation or deproteinizationp reservation on blood collected for ascorbic acid analysis using three di¡erent types of collection tubes.
Materials and methods

Specimen preservation
Blood for ascorbic acid analysis was collected into Vacutainer tubes (Becton Dickinson) containing either dipotassium EDTA (EDTA plasma), lithiumheparin (heparin plasma) or no additive (serum). EDTA plasma, heparin plasma and serum samples were each collected from ten subjects and then processed without delay.We then studied the e¡ects of delaying the separation of blood samples for 2 h followed by immediate deproteinization and preservation and also separating the blood samples immediately but delaying the deproteinization and preservation of the plasma or serum for 2, 5 and 8 h. Plasma or serum was mixed in a ratio of 1:1 with a solution of 2 g of DTT and 0¢2 g of EDTA per litre of 350 mmol/ L HClO 4 . Supernatants were stored at 7708C until assay.
Analysis of ascorbic acid
Analysis was performed by HPLC using a modi¢cation of the method described by Kindness and Miller. 6 The system comprised a 700 WISP autosampler, 600E solvent delivery system controller (Waters, Milford MA, USA) and an LC1260 electrochemical detector (GBC Scienti¢c Instruments, Melbourne, Australia) at ‡ 0¢700 V and 200 nA. The mobile phase, freshly prepared for each run, consisted of sodium acetate (1¢088 g), EDTA (0¢2 g) and tetrabutylammonium hydroxide (5¢0 mL) dissolved in 1 L of deionized water. The pH of the mobile phase was adjusted to 4 ¢ 0 with glacial acetic acid and ¢ltered through a 0 ¢ 45-mm Millipore ¢lter. It was degassed by sparging with helium at 50 mL/min for 30 min before use, and 20 mL/min thereafter, and pumped isocratically at a £ow rate of 1 ¢ 0 mL/min. Ascorbic acid was separated over a total run time of 10 min following injection of 5 mL into a Beckman Ultrasphere ODS 5 mm, 4¢6 mm615 cm, column (Fullerton CA, USA) thermostated at a constant temperature of 308C. Ascorbic acid eluted after urate, from which it was clearly resolved. Waters Millennium Chromatography Manager software was used for data processing.
Stock ascorbic acid standard solution (5678 mmol/ L) was made up in a solution containing 50 mmol/ L HClO 4 and 0 ¢ 27 mmol/ L EDTA and protected from light. Working standards were freshly prepared for each run by diluting stock standard with saline to achieve concentrations of 113¢6, 85¢2, 68¢1, 45¢4, 22¢7 and 11¢4 mmol/L. These working standards were then diluted in a ratio of 1:1 with the same deproteinizingp reservation solution used for preserving the plasma or serum. Imprecision, determined using deproteinized and preserved plasma pools, was: intra-assay percentage coe¤cient of variation (%CV) 4¢5, mean 23¢8 mmol/L (nˆ48); inter-assay %CV 5¢6, mean 20¢4 mmol/L (nˆ50).
Results and discussion
When the samples were processed immediately after collection, EDTA plasma samples gave the highest median ascorbic acid concentration (69 ¢ 3 mmol/L, range 15 ¢ 9^153 ¢ 3) for ten subjects. Ascorbic acid concentrations were lower in heparin plasma by 0^26% (median 7%) and in serum by 4^29% (median 14%). We therefore used the results of the EDTA plasma samples (processed without delay) as baseline values to calculate the losses observed in the delayed separation and delayed deproteinization^preservation experiments. Table 1 shows the e¡ects of delaying the separation of EDTA plasma, heparin plasma or serum for 2 h in blood samples from ten subjects collected into each of the three types of tube. Losses of ascorbic acid were observed from all three types of tube, but the least loss occurred in the EDTA tubes.
The medians were found to be signi¢cantly di¡erent (P50¢01) using Paired Samples Statistics, SSPS Version 10. Separating plasma or serum from cells immediately but storing at 48C for 2, 5 and 8 h before deproteinization and preservation also resulted in substantial losses of ascorbic acid (see Table 2 ). The losses of ascorbic acid observed in each case were independent of concentration. Paradoxically, although ascorbic acid was more stable in EDTA blood than in either heparin or clotted blood, losses from stored EDTA plasma were greater than from stored heparin plasma or serum.
In conclusion, we have shown that substantial losses of ascorbic acid can occur during sample collection and handling and that great care needs to be exercised to minimiz e this source of preanalytical error if meaningful results are to be obtained. Collection of blood into EDTA is recommended and we demonstrate there are minimal losses of ascorbic acid if EDTA plasma is separated within 2 h followed by immediate deproteinization and preservation.
